@misc{10481/72521,
year = {2021},
month = {12},
url = {http://hdl.handle.net/10481/72521},
abstract = {Alzheimer's disease (AD) is the most common cause of dementia. It is characterized by cognitive decline and progressive memory loss. The aim of this review was to update the state of knowledge on the pathophysiological mechanisms, diagnostic methods and therapeutic approach to AD. Currently, the amyloid cascade hypothesis remains the leading theory in the pathophysiology of AD. This hypothesis states that amyloid-beta (A beta) deposition triggers a chemical cascade of events leading to the development of AD dementia. The antemortem diagnosis of AD is still based on clinical parameters. Diagnostic procedures in AD include fluid-based biomarkers such as those present in cerebrospinal fluid and plasma or diagnostic imaging methods. Currently, the therapeutic armory available focuses on symptom control and is based on four pillars: pharmacological treatment where acetylcholinesterase inhibitors stand out; pharmacological treatment under investigation which includes drugs focused on the control of A beta pathology and tau hyperphosphorylation; treatment focusing on risk factors such as diabetes; or nonpharmacological treatments aimed at preventing development of the disease or treating symptoms through occupational therapy or psychological help. AD remains a largely unknown disease. Further research is needed to identify new biomarkers and therapies that can prevent progression of the pathology.},
organization = {Junta de Andalucia
European Commission	P20-01293	
PECART-0096-2020},
organization = {Spanish Government
European Commission	PID2020-117544RB-100},
publisher = {MDPI},
keywords = {Alzheimer's disease},
keywords = {Senile plaques},
keywords = {beta-amyloid protein},
keywords = {Tau protein},
keywords = {Diagnosis},
keywords = {Biomarker},
keywords = {Treatment},
keywords = {Acetylcholinesterase inhibitors},
keywords = {Immunotherapy},
title = {Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease},
doi = {10.3390/biomedicines9121910},
author = {García Morales, Victoria and González Acedo, Anabel and Melguizo Rodríguez, Lucía Raquel and Costela Ruiz, Víctor Javier and Montiel Troya, María and Ramos Rodríguez, Juan José},
}